Registration Strip Icon for default Cadastre-se gratuitamente para obter cotações em tempo real, gráficos interativos, fluxo de opções ao vivo e muito mais.

SHR

Schering Aktiengesel (SHR)

Bank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NYSE:SHR
DataHoraFonteTítuloCódigoCompanhia
19/01/200706:20PR Newswire (US)Bayer Schering Pharma to Develop New Imaging Compounds for Detection of Neurodegenerative DiseasesNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
05/12/200611:25PR Newswire (US)Bayer Determines EUR 98.98 as Cash Compensation per Schering ShareNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
28/11/200606:45PR Newswire (US)Schering AG and Stanford University to Cooperate in the Field of Molecular ImagingNYSE:SHR
27/11/200605:33PR Newswire (US)Schering AG Maintains Strong Growth Momentum During First Nine Months of 2006NYSE:SHR
24/11/200615:25PR Newswire (US)NYSE Suspends Trading in Schering ADRsNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
23/11/200607:40PR Newswire (US)Betaferon(R) Approved in Australia for Earliest Stages of Multiple SclerosisNYSE:SHR
08/11/200604:54PR Newswire (US)Go-Ahead for Schering's Integration Into the Bayer GroupNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
31/10/200610:00PR Newswire (US)Berlex Oncology Evaluating Combination Therapy for Common Form of Non-Hodgkin's LymphomaNYSE:SHR
30/10/200616:10PR Newswire (US)Entry in the Commercial Register - Agreement Between Bayer and Schering in Force - Resolution of Schering Extraordinary StockholNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
23/10/200611:39PR Newswire (US)FDA Approves Betaseron(R) for Use After the First Event Suggestive of Multiple SclerosisNYSE:SHR
17/10/200610:47PR Newswire (US)Family Planning Programs in the Fight Against PovertyNYSE:SHR
05/10/200609:30PR Newswire (US)FDA Approves New Indication for YAZ(R) to Treat Emotional and Physical Symptoms of Premenstrual Dysphoric Disorder (PMDD)NYSE:SHR
19/09/200604:58PR Newswire (US)Schering AG and Organon to Continue Research in Male Fertility Control SeparatelyNYSE:SHR
18/09/200611:01PR Newswire (US)Schering AG Licenses SEGRA Compound for Ophthalmic Use to Bausch & LombNYSE:SHR
15/09/200605:32PR Newswire (US)Schering AG and AstraZeneca Form Strategic Alliance to Develop Novel Anti-Cancer DrugNYSE:SHR
14/09/200611:00PR Newswire (US)MEDRAD Employees Care in a Big Way: Facilities Suspend Operations Today so That 800 Can Volunteer in CommunityNYSE:SHR
14/09/200609:48PR Newswire (US)Stockholders Pave the Way for Bayer Schering PharmaNYSE:SHR
13/09/200607:32PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG in BerlinNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
04/09/200608:19PR Newswire (US)Schering AG Completes Reconstruction Projects in Indonesia and ThailandNYSE:SHR
01/09/200611:00PR Newswire (US)MEDRAD Holds Job Fair To Support Company GrowthNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
30/08/200607:13PR Newswire (US)Group Environmental Report for 2006 PublishedNYSE:SHR
16/08/200612:50PR Newswire (US)Frost & Sullivan Lauds MEDRAD Excellent Product Innovation Abilities in the MRI Coils MarketNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
04/08/200605:15PR Newswire (US)Extraordinary Stockholders' Meeting of Schering AG on September 13, 2006: Schering's Stockholders to Resolve on Domination andNYSE:SHR
02/08/200611:00PR Newswire (US)New MEDRAD 3.0T Prostate eCoil(TM) Enables Personalized Treatment PlanningNYSE:SHR
31/07/200611:49PR Newswire (US)Berlex Voluntarily Recalls Ultravist(R) Injection 370 mgI/mLNYSE:SHR
31/07/200611:36PR Newswire (US)Schering AG, Germany Announces Results of Two Clinical Trials With Sargramostim in Crohn's Disease PatientsNYSE:SHR
31/07/200611:21PR Newswire (US)Schering Voluntarily Recalls Ultravist(R) Injection 370 mgI/mlNYSE:SHR
31/07/200611:20PR Newswire (US)Bayer Offer Remains Unchanged Despite Voluntary Ultravist(R) Injection 370 mgI/ml Recall and Insufficient Results of Clinical PNYSE:SHRBank of America Corp. Strategic Accelerated Redemption Securities Linked TO The S&P 500 Index
26/07/200615:46PR Newswire (US)KPMG Values Schering AG Share at EUR 87.63NYSE:SHR
25/07/200604:28PR Newswire (US)Schering AG Raises Outlook After Strong First Half YearNYSE:SHR
 Apresentando as notícias mais relevantes sobre:NYSE:SHR